Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 13,372 shares at $25.04 ($335K) on 2018-05-16, disclosed to the SEC on 2018-05-17.
Open-market sale of $335k NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.04 | 6,686 | $167K | 50.0% |
| 2 | $25.04 | 6,686 | $167K | 50.0% |
| Total | $25.04 avg | 13,372 | $335K | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |